Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Can hand dexterity predict the disability status of patients with multiple sclerosis?
Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNS.
Progression, Symptoms and Psychosocial Concerns among Those Severely Affected by Multiple Sclerosis: A Mixed-Methods Cross-Sectional Study of Black Caribbean and White British People.
[Actual medical care situation and therapeutic needs in multiple sclerosis : Impact of the Pharmaceutical Market Restructuring Act (AMNOG)].
Evoked potentials are useful for diagnosis of neuromyelitis optica spectrum disorder.
Immune response induced by Epstein-Barr virus and Mycobacterium avium subsp. paratuberculosis peptides in current and past infectious mononucleosis: a risk for multiple sclerosis?
Quality improvement in neurology: Multiple sclerosis quality measures: Executive summary.
Ethanol-Induced TLR4/NLRP3 Neuroinflammatory Response in Microglial Cells Promotes Leukocyte Infiltration Across the BBB.
Autoimmune neuropathies: insights from animal models.
Targeting semaphorins in MS as a treatment strategy to promote remyelination: A tale of mice, rats and men.
Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
Guanosine inhibits LPS-induced pro-inflammatory response and oxidative stress in hippocampal astrocytes through the heme oxygenase-1 pathway.
Mixed emotions: the contribution of alexithymia to the emotional symptoms of autism.
Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population.
Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Personality factors in recently diagnosed multiple sclerosis patients: a preliminary investigation with the NEO-FFI scale.
Cutting Edge: c-Kit Signaling Differentially Regulates Type 2 Innate Lymphoid Cell Accumulation and Susceptibility to Central Nervous System Demyelination in Male and Female SJL Mice.
Antiphospholipid antibodies: paradigm in transition.
Chondroitin sulfate proteoglycans impede myelination by oligodendrocytes after perinatal white matter injury.
No evidence of disease activity in multiple sclerosis: Implications on cognition and brain atrophy.
Treatment of Trigeminal Neuralgia Associated with Multiple Sclerosis.
α-Synuclein deficiency promotes neuroinflammation by increasing Th1 cell-mediated immune responses.
Fumaric Acid Esters Stimulate Astrocytic VEGF Expression through HIF-1α and Nrf2.
HDAC inhibitors mitigate ischemia-induced oligodendrocyte damage: potential roles of oligodendrogenesis, VEGF, and anti-inflammation.
Transverse myelitis and bilateral optic neuritis in a patient with systemic lupus erythematosus.
Pages
« first
‹ previous
…
669
670
671
672
673
674
675
676
677
…
next ›
last »